Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

March 10, 2025

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

March 14, 2024

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

News Conference News

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

March 02, 2022

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

News Daily News CRT 2021

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

Michael O'Riordan

March 17, 2021

BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients

News Conference News CRT 2021

BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients

March 16, 2021

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

News Daily News CRT 2020

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

Michael O'Riordan

March 04, 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

News Conference News CRT 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Michael O'Riordan

February 25, 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

February 25, 2020

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

News Conference News CRT 2020

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

Michael O'Riordan

February 24, 2020

ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice

News Conference News CRT 2019

ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice

Yael L. Maxwell

March 07, 2019

Rivaroxaban in Addition to DAPT Lowers Death, MI, Stroke in ACS, Heart Failure Patients: Meta-analysis

News Conference News CRT 2019

Rivaroxaban in Addition to DAPT Lowers Death, MI, Stroke in ACS, Heart Failure Patients: Meta-analysis

Yael L. Maxwell

March 03, 2019

Radial Access PCI Reduces Risk of Mortality and Bleeding in VALIDATE-SWEDEHEART

News Conference News CRT 2018

Radial Access PCI Reduces Risk of Mortality and Bleeding in VALIDATE-SWEDEHEART

Michael O'Riordan

March 06, 2018

Same-Day Discharge After Transradial PCI Safe, Feasible, With Significant Cost Savings

News Conference News CRT 2017

Same-Day Discharge After Transradial PCI Safe, Feasible, With Significant Cost Savings

Michael O'Riordan

February 23, 2017

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

News Conference News CRT 2017

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Michael O'Riordan

February 21, 2017

News Conference News CRT 2016

Registry Behind TASTE Reopens Thrombus Aspiration Question With New Analysis of Stent Thrombosis

February 22, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.